A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2009
11/19/2009	WO2009139506A1 Combination of drugs having different physical properties into single dosage form
11/19/2009	WO2009139459A1 Method for prevention and treatment of metabolic syndrome through the inhibition of psgl-1
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139362A1 Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009139343A1 Antitumor agent, kit and method of treating cancer
11/19/2009	WO2009105218A3 Propiophenone derivatives
11/19/2009	WO2009088192A9 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
11/19/2009	US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009	US20090286865 Potentiator of antitumoral agents in the treatment of cancer
11/19/2009	US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009	US20090286855 Interleukin-18 mutants, their production and use
11/19/2009	US20090286821 Inhibitors of tyrosine kinases
11/19/2009	US20090286809 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/19/2009	US20090286796 Compounds exhibiting type X sPLA2 inhibiting effect
11/19/2009	US20090286794 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/19/2009	US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009	US20090286753 Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas
11/19/2009	US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009	US20090286735 Method for administering glp-1 molecules
11/19/2009	US20090286733 Long-acting veterinary polypeptides and methods of producing and administering same
11/19/2009	US20090286728 Tooth root formation promoting factors and method for promotion of tooth root formation
11/19/2009	US20090286717 Glycopeptide Antibiotic Derivative
11/19/2009	US20090285969 Pasteurisation process for microbial cells and microbial oil
11/19/2009	US20090285918 Cell-Proliferating Agent or Tissue-Repairing Agent Derived from White Rice
11/19/2009	US20090285903 Methods for dendritic cell therapy using pharmacologically active microcarriers
11/19/2009	US20090285887 Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor
11/19/2009	US20090285873 Implantable medical devices and coatings therefor comprising block copolymers of poly(ethylene glycol) and a poly(lactide-glycolide)
11/19/2009	US20090285855 Recombinant vaccine against japanese encephalitis virus (jev) infection and a method thereof
11/19/2009	US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009	US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
11/19/2009	US20090285816 Albumin Fusion Proteins
11/19/2009	US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009	US20090285761 Renal Function Analysis Method and Apparatus
11/19/2009	US20090285756 11c/18 f-labeled inhibitors of glycogen synthase kinase-3
11/19/2009	CA2724435A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009	CA2724133A1 Medicine consisting of concomitant use or combination of dpp-iv inhibitor and other diabetic medicine
11/19/2009	CA2724077A1 Amide compound
11/19/2009	CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/18/2009	EP2119785A1 Novel peptides
11/18/2009	EP2119778A1 Method for activation of helper t cell and composition for use in the method
11/18/2009	EP2119719A1 Thiazepine derivative
11/18/2009	EP2119716A1 Aza-bridged-ring compound
11/18/2009	EP2119715A1 Benzimidazole derivative and its use as aii receptor antagonist
11/18/2009	EP2119707A1 Composition for treatment of undifferentiated-type of gastric cancer
11/18/2009	EP2119704A1 Acylguanidine derivative
11/18/2009	EP2119702A1 Amide derivative
11/18/2009	EP2119443A1 Composition for prevention or treatment of disease associated with thrombus or embolus
11/18/2009	EP2117595A2 Remotely triggered release from heatable surfaces
11/18/2009	EP1873148B1 Pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid
11/18/2009	EP1529049B1 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
11/18/2009	EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009	EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009	EP1413303B1 Swine growth promoters and method of promoting swine growth
11/18/2009	EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use
11/18/2009	EP1280781B1 5-ht 7 receptor antagonists
11/18/2009	EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009	EP1207873B1 Methods of inhibiting osteoclast activity
11/18/2009	EP0892789B2 Irreversible inhibitors of tyrosine kinases
11/18/2009	EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009	EP0662133B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
11/18/2009	CN101583377A Treatment of fibrosis
11/18/2009	CN101583367A Materials and methods for treating and managing angiogenesis-mediated diseases
11/18/2009	CN101583366A Radiation sensitizer or anti-cancer chemotherapy sensitizer
11/18/2009	CN101580536A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/18/2009	CN101580511A Application of novel xyloketal compound in marine fungal from South China Sea in preparation of intracellular anti-oxidation stress medicine
11/18/2009	CN101579455A Traditional Chinese medicine preparation for treating consumptive disease
11/18/2009	CN101579352A Application of polysaccharide component of longan pulp in pharmacy
11/18/2009	CN100560073C N4-acylcytosine nucleosides for treatment of viral infections
11/17/2009	US7619100 Physiologically active substances
11/17/2009	US7618994 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis
11/17/2009	US7618977 Method of treating dermatitis comprising administering a chymase inhibitor
11/17/2009	US7618967 Indane compounds
11/17/2009	US7618963 Bicyclic heteroaromatic compounds
11/17/2009	US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
11/17/2009	US7618955 Association of an antithrombotic and aspirin
11/17/2009	US7618942 Controlling insects by contacting with insecticidal Bacillus thuringiensis hybrid protein comprising domains I and II of first native B. thuringiensis delta-endotoxin Cry1A protein, domain III of second native B. thuringiensis delta-endotoxin Cry1F protein, and protoxin segment of native delta endotoxin
11/17/2009	US7618941 Treating degenerative joint disorders with tribonectins
11/17/2009	US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009	US7618787 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelarator and apoptosis inhibitor
11/17/2009	US7618658 applying a Sasa plant extract on skin for treating Propionibacterium infections
11/17/2009	US7618638 Matrix metalloprotease inhibitor
11/17/2009	US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
11/17/2009	US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009	US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
11/17/2009	CA2588495C The utility of uridine nucleosides in the treatment of cachexia
11/17/2009	CA2535511C Compounds having thrombopoietin receptor agonism
11/17/2009	CA2522051C Diamine derivative, production process therefor and antioxidant
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009	CA2441239C Mch antagonists and their use in the treatment of obesity
11/17/2009	CA2417082C New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
11/17/2009	CA2411172C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
11/17/2009	CA2399299C Compounds with chelation affinity and selectivity for first transition series elements and their use
11/17/2009	CA2397450C Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
11/17/2009	CA2397244C Ace inhibitor-vasopressin antagonist combinations
11/17/2009	CA2396062C Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity
11/17/2009	CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009	CA2382296C Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
11/17/2009	CA2341429C Treatment of mucus hypersecretion
11/17/2009	CA2336822C Method of treatment and pharmaceutical composition

1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 1564